Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Alfarm is a prominent pharmaceutical marketing and distribution company based in Russia, specializing in providing comprehensive market access and promotion services for international manufacturers. Since its founding in 1997, the company has established a robust infrastructure for the registration, promotion, and logistics of both innovative and generic medicinal products across the Russian Federation and CIS countries. Alfarm acts as a strategic partner for global pharmaceutical firms, managing regulatory affairs, pharmacovigilance, and specialized sales force operations to ensure successful product commercialization. Their portfolio covers a wide range of therapeutic areas, including rheumatology, neurology, oncology, and gastroenterology. By bridging the gap between international developers and the regional healthcare market, Alfarm plays a critical role in expanding patient access to essential therapies in Eastern Europe and Central Asia.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Alfarm.